Eliezer Van Allen

Eliezer Van Allen, MD, is an Associate Professor of Medicine at Harvard Medical School and Chief of the Division of Population Sciences at Dana-Farber Cancer Institute. He holds the Chandra Nohria Family Chair for AI in Cancer Research. His research focuses on clinical computational oncology, integrating genomics, artificial intelligence, and clinical data to advance precision cancer medicine. Key areas include tumor immune interactions, genomic drivers of resistance to therapies, and inherited genetic risk factors in pediatric and adult cancers.

Education: Medical degree from the University of California, Los Angeles (UCLA), followed by residency in Internal Medicine at the University of California, San Francisco (UCSF), and a fellowship in Medical Oncology at Dana-Farber/Partners CancerCare.

Research Interests: Computational oncology, cancer genomics, immunotherapy response mechanisms, and AI-driven biomarker discovery. His lab develops tools like the Molecular Oncology Almanac and collaborates on patient-partnered initiatives such as the Metastatic Prostate Cancer Project. Recent work emphasizes germline variants in pediatric cancers, myeloid-mediated resistance in prostate cancer, and biologically interpretable AI models for tumor analysis.

Awards: Recognized as one of the world's most highly cited researchers in cancer genomics (2024). Holds the Chandra Nohria Chair for AI in Cancer Research.

Advising & Grants: Mentored over 20 students, including Kevin, Nicita Mehta, and Samantha Hoffman. His lab’s work is supported by grants focused on computational oncology, precision medicine, and AI ethics in healthcare.

Labs/Teams: Director of the Clinical Computational Oncology Lab at Dana-Farber, which combines computational biology, clinical data science, and translational research. Collaborates with institutions like the Broad Institute and patient advocacy groups.